PROTARA THERAPEUTICS INC filings

SEC filings by PROTARA THERAPEUTICS INC (ownership)
TypeFiledFilerSubjectShares OwnedPercent Owned
SC 13G2024-04-25RA CAPITAL MANAGEMENT, L.P.Protara Therapeutics, Inc.2,073,07510.0%EDGAR
SC 13G2024-04-22CITADEL ADVISORS LLCProtara Therapeutics, Inc.-5.7%EDGAR
SC 13G2024-04-09CVI Investments, Inc.Protara Therapeutics, Inc.600,3805.3%EDGAR
SC 13G/A2024-02-14ORBIMED ADVISORS LLCProtara Therapeutics, Inc.00.0%EDGAR
SC 13G/A2023-02-14ORBIMED ADVISORS LLCProtara Therapeutics, Inc.671,7416.0%EDGAR
SC 13G/A2022-02-15Rock Springs Capital Management LPProtara Therapeutics, Inc.00.0%EDGAR
SC 13G/A2022-02-15PERCEPTIVE ADVISORS LLCProtara Therapeutics, Inc.421,6413.8%EDGAR
SC 13G/A2022-02-14Ikarian Capital, LLCProtara Therapeutics, Inc.279,2562.5%EDGAR
SC 13G2022-02-11ORBIMED ADVISORS LLCProtara Therapeutics, Inc.671,7416.0%EDGAR
SC 13G/A2021-02-16Rock Springs Capital Management LPProtara Therapeutics, Inc.643,2005.7%EDGAR
SC 13G/A2021-02-16PERCEPTIVE ADVISORS LLCProtara Therapeutics, Inc.608,5445.4%EDGAR
SC 13G/A2021-02-12Ikarian Capital, LLCProtara Therapeutics, Inc.649,5425.8%EDGAR
SC 13D/A2021-01-08Flynn James EProtara Therapeutics, Inc.00.0%EDGAR
SC 13G2020-10-02Rock Springs Capital Management LPProtara Therapeutics, Inc.643,6226.2%EDGAR
SC 13G2020-10-01PERCEPTIVE ADVISORS LLCProtara Therapeutics, Inc.608,5445.8%EDGAR
SC 13D/A2020-09-25Opaleye Management Inc.Protara Therapeutics, Inc.2,508,47223.9%EDGAR
SC 13G2020-02-21Ikarian Capital, LLCArTara Therapeutics, Inc.307,3085.3%EDGAR
SC 13G/A2020-02-14INTERSOUTH PARTNERS VI LPArTara Therapeutics, Inc.32,510-EDGAR
SC 13D/A2020-01-27Opaleye Management Inc.ArTara Therapeutics, Inc.2,208,47237.8%EDGAR
SC 13D2020-01-21Opaleye Management Inc.ArTara Therapeutics, Inc.2,208,47237.8%EDGAR